慢性肾脏病患者生存预测模型与风险分层工具
该研究基于NHANES 1999-2004队列中5062例CKD≥2期患者,开发并验证了预测2年死亡率的风险评分系统(R评分0-10分)及预测模型。模型AUC为0.83(95%CI 0.81-0.86),高风险组预测与观察死亡率接近,可用于临床量化CKD患者个体死亡风险。
要点
- R评分基于年龄、性别、CKD分期、蛋白尿、吸烟和合并症计算,范围0-10分。
- 模型预测2年死亡率的AUC为0.83,区分能力良好。
- R≥4-5、>5-6和>6组预测2年死亡率分别为3.8%、6.4%和13.0%。
核心结论
- 风险分层工具和2年死亡率预测模型表现良好,可用于临床量化CKD患者个体死亡风险。
研究设计与样本
- 应用Woodpecker方法开发线性、指数和组合预测方程,使用NHANES 1999-2004队列中5062例CKD≥2期患者进行验证。
主要发现
- R评分预测2年死亡率的AUC为0.83(95%CI 0.81-0.86),队列2年死亡率为3.2%。
- 组合模型在全人群和各CKD分期中结果最接近实际结局。
- R≥4-5、>5-6和>6组预测2年死亡率分别为3.8%、6.4%和13.0%,观察死亡率分别为2.7%、4.5%和13.3%。
关键数值与推荐
- R评分计算:起点0,年龄每超过20岁每年加0.048,男性加0.45,CKD分期每高于2期一级加0.49,蛋白尿加1.04,吸烟史加0.72,每种显著合并症加0.49(最多5种)。
临床怎么用
- 可用于CKD≥2期患者个体化2年死亡风险量化,辅助识别需要治疗干预的高危患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Because chronic kidney disease (CKD) adversely affects survival, prediction of mortality risk should help to identify individuals requiring therapeutic intervention. The goal of this project was to construct and to validate a risk scoring system and prediction model of the probability of 2-year mortality in a CKD population. METHODS: We applied the Woodpecker approach to develop prediction equations using linear, exponential, and combined models. A risk indicator R on a scale of 0 to 10 was calculated as follows: starting with 0, add 0.048 for each year of age above 20, 0.45 for male sex, 0.49 for each stage of CKD over stage 2, 1.04 for proteinuria, 0.72 for smoking history, and 0.49 for each significant comorbidity up to 5. RESULTS: Using R to predict 2-year mortality, the model yielded an area under the receiver operating characterisic curve of 0.83 (95% confidence interval = 0.81-0.86) with 5062 subjects with CKD ≥stage 2 from a National Health and Nutrition Examination Survey cohort (1999-2004) having a 3.2% 2-year mortality. The combined expression offered results closest to most actual outcomes for the entire population and for each CKD stage. For those patients with higher risk (R ≥ 4-5, >5-6, and >6), the predicted 2-year mortality rates were 3.8%, 6.4%, and 13.0%, respectively, compared to observed mortality rates of 2.7%, 4.5%, and 13.3%. CONCLUSION: The risk stratification tool and prediction model of 2-year mortality demonstrated good performance and may be used in clinical practice to quantify the risk of death for individual patients with CKD.
引用
- Goldfarb-Rumyantzev AS, Gautam S, Dong N, et al. Prediction Model and Risk Stratification Tool for Survival in Patients With CKD. Kidney Int Rep. 2017. PMID: 29725646. doi:10.1016/j.ekir.2017.11.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。